Rajaa Arnaout: Platelet Removal and the Brain’s Neural Stem Cell Niche
Rajaa Arnaout, Biomedical Science Student at the University of Westminster, shared a post on LinkedIn:
“Hitting ‘submit’ on my dissertation now feels like a distant memory, but I still remember that final click so clearly.
Looking back, it’s hard to believe how quickly time has flown. My dissertation, ‘Investigation of the Effects of Platelet Removal on the Brain’s Neural Stem Cell Niche’, marked one of the most challenging yet rewarding parts of my degree. There were moments of doubt, long nights, and plenty of pressure — but also a huge amount of learning and growth that came with it.
Now that I’ve received my results, I feel an overwhelming sense of pride in what I’ve achieved. Not just for the final outcome, but for the persistence it took to get there in the first place.
I’m especially grateful to my supervisor, Ilias Kazanis, for his guidance, patience, and support throughout the process; it genuinely shaped this journey.
A chapter I’ll always look back on with pride… and a reminder of how far I’ve come.”

Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian